Delivery Order M6700111D1001-0002
Award Date 8/11/11
Potential Completion Date 12/6/11
Potential Value $135K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
Total Small Business
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Camp Lejeune, NC 28542, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
2
Legislative Mandate
Service Contract Act
National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This $27,610.40 delivery order against the Pharmaceuticals and Drugs Federal Supply Schedule was awarded by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 8 to QOL Medical LLC. To be completed by December 14, 2022, the firm fixed price order is for emergency procurement of the prescription medication Sucraid. Placed under Schedule 61-IB and with performance in Vero Beach, Florida, this award continues the VA's efforts to provide critical...
- QOL Medical LLC was awarded an $11,044.16 delivery order against the Pharmaceuticals and Drugs Federal Supply Schedule by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 9. The firm fixed price order is for emergency medicine supplies under schedule contract FSS-61-IB and has an anticipated completion date of August 6, 2021. Performance will take place in Murfreesboro, Tennessee. No set-aside designation was applied to this order to fulfill...
- This delivery order against the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) was awarded by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 5 to Travere Therapeutics, Inc. for the delivery of THIOLA 100 MG tablets. Valued at $11,992.26, the firm fixed price contract has a period of performance through May 8, 2023 to supply the requested pharmaceutical product to support healthcare services for veterans in the San Diego,...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at four hundred thirty-one dollars to Amerisourcebergen Drug Corporation for the supply of one hundred capsules of Vyvanse, a Schedule II controlled substance. As the prime contractor, Amerisourcebergen Drug Corporation will deliver the pharmaceutical products to a customer located in Conshohocken, Pennsylvania under a contract scheduled for completion by September 29, 2023. The Defense Logistics Agency routinely...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at four hundred thirty-one dollars to Amerisourcebergen Drug Corporation for the supply of one hundred capsules of Vyvanse, a Schedule II controlled substance used to treat attention deficit hyperactivity disorder. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a three-day period in early July 2023. The prime contractor, Amerisourcebergen Corporation, is a major pharmaceutical...
- The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 21 has awarded a $14,584.53 delivery order against the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) to Actelion Pharmaceuticals US, Inc. for UPTRAVI - EMERGENCY ORDER. The firm fixed price order is for the delivery of pharmaceutical products to support the VA network's healthcare programs and has a completion date of April 30, 2023. No set-aside designation was applied to this...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,070.16 for 100 capsules of Lisdexamfetamine 40 mg, a Schedule II controlled substance commonly prescribed for attention deficit hyperactivity disorder. This firm fixed-price delivery order, awarded on October 29, 2025, with an ultimate completion date of October 30, 2025, was competitively awarded with no set-aside designation. The order will be fulfilled from AmerisourceBergen's location in...
- Actelion Pharmaceuticals US, Inc. was awarded a $9,050.62 delivery order against the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) by the Department of Justice Bureau of Prisons Federal Medical Center Carswell. The firm fixed price order is for the delivery of 30 bottles of CURASCRIPT OPSUMIT 10MG tablets to the Lake Mary, Florida facility by May 30, 2023. The order was placed on May 1, 2023 under the Pharmaceuticals and Drugs schedule, which provides access to prescription and...
- The Defense Logistics Agency awarded a $254 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 4562070881 Quillivant XR 25 MG/5 ML suspension. As the prime contractor, Amerisourcebergen will deliver 180mL of the prescribed medication to a location in Conshohocken, Pennsylvania under a one-day period of performance beginning September 6, 2023. The order was placed utilizing Amerisourcebergen's Federal Supply Schedule contract vehicle and supports the Defense...
- The Defense Logistics Agency awarded a delivery order valued at $1,240.57 to AmerisourceBergen Drug Corp for 100 capsules of Lisdexamfetamine 40 mg, a Schedule II controlled substance commonly prescribed for attention-deficit/hyperactivity disorder. The contract was competitively awarded on June 25, 2025, with an ultimate completion date of June 26, 2025, and is classified as a firm fixed-price delivery order with no set-aside designation. Performance will occur at AmerisourceBergen's...
- M6700111D1001Indefinite Delivery Contract
- M6700111D1001-0002Delivery Order
SCHEDULE I THROUGH IV
Posted 8/9/11
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
DEPLOYMENT STORAGE SERVICES | M6700111T1004 | United States Marine Corps | Award Notice 1/1 | 2/16/11, 2:26 PM |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| 2 | Change Order | $0 | 12/9/11 | |
| 1 | Change Order | $60.0k | 9/26/11 | |
| Not listed | Not listed | $75.0k | 8/9/11 |